awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35180066-3D370374-6B6D-45B7-98CF-0D929701E600
Q35180066-3D370374-6B6D-45B7-98CF-0D929701E600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35180066-3D370374-6B6D-45B7-98CF-0D929701E600
Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.
P2860
Q35180066-3D370374-6B6D-45B7-98CF-0D929701E600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35180066-3D370374-6B6D-45B7-98CF-0D929701E600
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4caa8d3267d31a3eaf3f7563ecdfdbc761fbb434
P2860
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.